title: Interstitial nephritis in children with Crohn's disease.
authors.forename: N
authors.initials: N
authors.lastname: Benador
authors.forename: P
authors.initials: P
authors.lastname: Grimm
authors.forename: J
authors.initials: J
authors.lastname: Lemire
authors.forename: W
authors.initials: W
authors.lastname: Griswold
authors.forename: G
authors.initials: G
authors.lastname: Billman
authors.forename: V
authors.initials: V
authors.lastname: Reznik
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019804:Mesalamine / Q000009:adverse effects* / Q000627:therapeutic use; D009395:Nephritis, Interstitial / Q000139:chemically induced*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine; D011241:Prednisone